An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies

Authors

Keywords

Journal

Volume 23, Issue 6, Pages 1368-1372

Publisher

American Association for Cancer Research (AACR)

Online

2016-12-20

DOI

10.1158/1078-0432.ccr-16-1098

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now